Keyphrases
CD8+ T Cells
88%
Antitumor Effect
67%
Klebsiella Pneumoniae B5055
62%
PD-1 Blockade
62%
Biofilm
62%
Programmed Death-ligand 1 (PD-L1)
57%
Bacteriophage
52%
Lytic Bacteriophage
48%
Phage
44%
Dendritic Cells
42%
PD-1 Resistance
41%
Maternal Obesity
41%
Phosphoinositide 3-kinase (PI3K)
41%
Therapeutic Vaccine
41%
Ciprofloxacin
41%
Klebsiella Pneumoniae (K. pneumoniae)
37%
Tumor
35%
Tumor Cells
30%
Norovirus
29%
FlaB
29%
Cancer Immunotherapy
29%
Vibrio Vulnificus
27%
Potential Therapeutics
26%
Immune Cells
26%
Biofilm Eradication
26%
Tumor Suppression
25%
P Domain
25%
Adjuvanted
25%
Recombinant
25%
Flagellin
25%
Tumor Microenvironment
24%
Tumor Immune Response
23%
CD8+ T Lymphocytes
23%
Intranasal Route
23%
Intranasal
23%
Cancer Cells
21%
Antitumor
21%
Siderophore
20%
Antibiotic Resistance
20%
Combination Immunotherapy
20%
Molecular Characterization
20%
2,3-dihydroxybenzoic Acid
20%
Gut Dysbiosis
20%
Escherichia Coli
20%
Agonist Antibody
20%
Breast Cancer Treatment
20%
Anticancer Therapy
20%
Solid Cancer
20%
OX40 Agonist
20%
T Memory Stem Cells
20%
Immunology and Microbiology
Bacteriophage
87%
Klebsiella pneumoniae
83%
Immunity
64%
Immune Response
64%
Biofilm
62%
T Cell
59%
Dendritic Cell
48%
Cytotoxic T-Cell
41%
Immunotherapy
35%
Cancer Immunotherapy
32%
Immunocompetent Cell
32%
Norovirus
31%
Flagellin
29%
Vibrio vulnificus
29%
Tumor Cell
28%
Adjuvant
27%
Regulatory T Cell
27%
Cancer Cell
27%
Immunology
27%
Cytosol
26%
Immunosuppressive Drug
25%
CD8
24%
Agonist
24%
Tumor Antigen
23%
Tumor Vaccine
23%
T Cell Subset
20%
T-Helper Cell
20%
Regulatory Cell
20%
CD8+ T Lymphocyte
20%
Antimicrobial Resistance
20%
Progeny
20%
Escherichia coli
20%
Stem Cell
20%
Secretory Immunoglobulin
20%
Myeloid
20%
Salicylic Acid
20%
NLRC4
20%
Intravenous Immunoglobulin
20%
Inflammasome
20%
Intestine Flora
20%
Antigen Specificity
18%
Adoptive Immunity
17%
Feces
17%
Toll-Like Receptor
17%
Lymph Node
15%
Effector Cell
13%
Microflora
13%
Peptide Vaccine
11%
Deletion Mutant
10%
T Cell Receptor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
CD8 Antigen
77%
Malignant Neoplasm
45%
Bacteriophage
45%
Klebsiella pneumoniae
41%
Maternal Obesity
41%
Breast Cancer
41%
Immunotherapy
33%
Norovirus
31%
Flagellin
29%
Adjuvant
27%
Cancer Inhibition
25%
Intranasal Route
24%
Tumor Vaccine
23%
Tumor Microenvironment
21%
Indoleamine 2,3 Dioxygenase
20%
Tumor Regression
20%
Escherichia coli
20%
Genital Tract Cancer
20%
Sublingual Route
20%
Immunoglobulin
20%
Dimer
20%
Cancer Recurrence
20%
Breast Tumor
20%
Dysbiosis
20%
Therapeutic Vaccine
20%
Inflammasome
20%
Ciprofloxacin
20%
Amoxicillin
20%
Secretory Immunoglobulin
20%
Antibiotic Resistance
20%
Toll Like Receptor 5
17%
Combination Therapy
12%
Tamoxifen
12%
Tumor Growth
11%
Antibiotics
11%
Tumor Antigen
11%
Infection
10%
Intestine Flora
8%
Immune Checkpoint Inhibitor
8%
Short Chain Fatty Acid
8%
Vibrio vulnificus
8%
Gastroenteritis
8%
Antiestrogen
8%
7,12-Dimethylbenz(a)anthracene
8%
Tumor Recurrence
8%
Immunoglobulin A
6%
Freund's Adjuvant
6%
Human Papillomavirus
6%
Drug Resistance
5%
